|Robert E. Bolcome, III, Ph.D.|
Robert Bolcome was born in Gloucester, Massachusetts in 1982. He earned a B.S. in Biology from Northeastern University in 2005 and a Ph.D. in Cell and Developmental Biology from Harvard University in 2010. Dr. Bolcome’s graduate studies focused on the characterization of host cell signaling processes involved in anthrax toxin-induced cardiovascular defects. His research encompassed the areas of angiogenesis, microbial pathogenesis, cancer biology, and cell biology. Dr. Bolcome was a recipient of the Manfred Karnovsky Fellowship.
Dr. Bolcome is currently an evening student at Fordham University School of Law where he is a Wilkinson Scholar and Fordham Law Review staff member. He is also a student member of the American Bar Association and is registered to practice before the U.S. Patent and Trademark Office.
Juris J.J., Melnyk R.A., Bolcome R.E., III, Chan J., Collier R.J. Cross-linked Forms of the Isolated N-terminal Domain of the Lethal Factor are Potent Inhibitors of Anthrax Toxin. Infection and Immunity. 2007 Oct; 75(10): 5052-8.
Bolcome R.E., III, Sullivan S.E., Zeller R., Barker A.P., Collier R.J., and Chan J. Anthrax Lethal Toxin Induced Cell Death-Independent Permeability in Zebrafish Vasculature. PNAS. 2008 Feb 19;105(7):2439-44.
Gryllos I., Tran-Winkler H.J., Cheng M.F., Chung H., Bolcome R.E., III, Lu W., Lehrer R.I., Wessels M.R. Induction of Group A Streptococcus Virulence by a Human Antimicrobial Peptide. PNAS. 2008 Oct 28;105(43):16755-60.
Vasil M.L., Stonehouse M.J., Vasil A.I., Wadsworth S.J., Goldfine H., Bolcome R.E., III, Chan J. A Novel Extracellular Sphingomyelinase of Pseudomonas aeruginosa Inhibits Angiogenesis by Selective Cytotoxicity to Endothelial Cells. PLoS Pathog. 2009 May; 5(5): e1000420.
Bolcome R.E., III and Chan J. Constitutive MEK1 Activation Rescues Anthrax Lethal Toxin Induced Vascular Effects In Vivo. Infection and Immunity. 2010 Sept 20. [Epub ahead of print]